Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Lifetime Data Analysis|January 30, 2026
Estimation of the interpretable heterogeneous treatment effect with causal subgroup discovery in survival outcomesNa Bo, Ying DingHeliyon|February 29, 2024
Can greater openness improve green economy efficiency of countries along the Belt and Road Initiative?Wei Ma, Na Bo, Xinmin WangActa Crystallographica. Section E, Structure Reports Online|June 22, 2012
2,5-Bis[(3-chloro-benz-yl)sulfan-yl]-1,3,4-thia-diazoleNa-Bo Sun, Jian-Zhong Jin, Wei KeActa Crystallographica. Section E, Structure Reports Online|June 22, 2012
N(1),N(4),3,6-Tetra-methyl-1,2,4,5-tetra-zine-1,4-dicarboxamideNa-Bo Sun, Guo-Wu Rao, Qun ShenBiomed Research International|April 11, 2015
Microwave assisted synthesis, antifungal activity, and DFT study of some novel triazolinone derivativesNa-Bo Sun, Jian-Zhong Jin, Fang-Yue HeActa Crystallographica. Section E, Structure Reports Online|June 22, 2012
1-{[3-(2-Chloro-3,3,3-trifluoro-prop-1-en-yl)-2,2-dimethyl-cyclo-propan-1-yl]carbon-yl}-3-(methyl-sulfon-yl)imidazolidin-2-oneNa-Bo Sun, Guo-Wu Rao, Jian-Bo ChuActa Crystallographica. Section E, Structure Reports Online|March 14, 2012
3,6-Bis(4-chloro-phen-yl)-N,N-bis-(1-phenyl-eth-yl)-1,2,4,5-tetra-zine-1,4-di-carboxamideNa-Bo Sun, Jia-Bin Ni, Guo-Wu RaoActa Crystallographica. Section E, Structure Reports Online|June 22, 2012
3-(2-Chloro-3,3,3-trifluoro-prop-1-en-1-yl)-2,2-dimethyl-N-[3-(trifluoro-meth-yl)phen-yl]cyclo-propane-carboxamideGuo-Wu Rao, Xiao-Min Li, Na-Bo SunStatistics in Medicine|January 24, 2025
Evaluating Meta-Learners to Analyze Treatment Heterogeneity in Survival Data: Application to Electronic Health Records of Pediatric Asthma Care in COVID-19 PandemicNa Bo, Jong-Hyeon Jeong, Erick Forno, et al.Acta Crystallographica. Section E, Structure Reports Online|March 14, 2012
(3,6-Dimethyl-1,2,4,5-tetra-zine-1,4-di-yl)bis-[(morpholin-4-yl)methanone]Na-Bo Sun, Yan-Mei Guo, Guo-Wu RaoPageof 5